Henan Taloph Pharma: 2025 Outlook, Dual‑Market Strategy & High P/E Growth
Explore TALOPH’s dual‑medicine strategy, strong financials, and growth outlook in China’s pharma market – a key player in traditional & Western medicines.
2 minutes to read
TALOPH